BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  WaferGen Biosystems Launches The ICELL8 Single-Cell System At American Society of Human Genetics

  October 6, 2015

   · 

  4 min read
• Biotech Beach

  Acutus Medical’s AcQMap High Resolution Imaging And Mapping System Provides High-Resolution Cardiac Mapping Combined With Exceptional Accuracy In Ultrasound Chamber Reconstruction In Patients With Atrial Fibrillation

  October 6, 2015

   · 

  4 min read
• Pharm Country

  Elusys Therapeutics, Inc. Awarded Additional $16 Million Under Existing U.S. Government Contract To Complete Development Of Lyophilized Form Of Anthim (Obiltoxaximab) For Treatment Of Inhalational Anthrax

  October 6, 2015

   · 

  5 min read
• BioMidwest

  Rho Clinical Research Expert To Exhibit At 2015 Annual North American Cystic Fibrosis Conference

  October 6, 2015

   · 

  2 min read
• Drug Development

  Regulus To Present Additional Preclinical Data Supporting RG-012 As A Novel microRNA Therapeutic In Development For Alport Syndrome At American Society of Nephrology’s Kidney Week 2015

  October 6, 2015

   · 

  9 min read
• Business

  LMK Clinical Research Consulting, LLC To Offer Expert Instruction On Trial Master File (TMF) Training In Online Xtalks Course

  October 6, 2015

   · 

  1 min read
• Biotech Bay

  Peter Thiel’s Breakout Labs Selects Four New Companies Pushing The Boundaries Of Science And Technology

  October 6, 2015

   · 

  6 min read
• Lone Star Bio

  Opexa Therapeutics Announces Granting Of New T-cell Patents Covering Tcelna; Patent Estate Increases To 160 Issued Patents

  October 6, 2015

   · 

  4 min read
• Drug Development

  Results From Merck & Co.’s Phase 3 Study Of Investigational Chronic Hepatitis C Therapy Elbasvir/Grazoprevir In Patients With Advanced Chronic Kidney Disease Published In Lancet

  October 6, 2015

   · 

  6 min read
• Business

  Verde Technologies Appoints Two New Members To Board Of Directors

  October 6, 2015

   · 

  3 min read